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Abstract:  
Background & Aims: Mucosal exposure devices improve detection of lesions during colonoscopy and have 
reduced examination times in uncontrolled studies. We performed a randomized trial of Endocuff Vision vs 
standard colonoscopy to compare differences in withdrawal time (the primary end point). We proposed that 
Endocuff Vision would allow complete mucosal inspection in a shorter time without impairing lesion detection. 
Methods: Adults older than 40 years undergoing screening or surveillance colonoscopies were randomly 
assigned to the Endocuff group (n=101, 43.6% women) or the standard colonoscopy group (n=99; 57.6% 
women). One of 2 experienced endoscopists performed the colonoscopies, aiming for a thorough evaluation of 
the proximal sides of all haustral folds, flexures, and valves in the shortest time possible. Inspection time was 
measured with a stopwatch and calculated by subtracting washing, suctioning, polypectomy and biopsy times 
from total withdrawal time. 
Results: There were significantly fewer women in the Endocuff arm (P=.0475) but there were no other 
demographic differences between groups. Mean insertion time with Endocuff was 4.0 min vs 4.4 min for 
standard colonoscopy (P=.14). Mean inspection time with Endocuff was 6.5 min vs 8.4 min for standard 
colonoscopy (P<.0001). Numbers of adenomas detected per colonoscopy (1.43 vs 1.07; P=.07), adenoma 
detection rate (61.4% vs 52%; P=0.21), number of sessile serrated polyps per colonoscopy (0.27 vs 0.21; 
P=0.12), and sessile serrated polyp detection rate (19.8% vs 11.1%; P= 0.09) were all higher with Endocuff 
Vision. Results did not differ significantly when we controlled for age, sex, or race. 
Conclusion: In a randomized trial, we found inclusion of Endocuff in screening or surveillance colonoscopies 
to decrease examination time without reducing lesion detection. ClinicalTrials.gov no.: NCT03361917 
KEY WORDS: colonoscopy, colorectal polyp, colon cancer; colorectal 
What You Need to Know  
Background: We performed a randomized trial of Endocuff Vision vs standard colonoscopy to compare 
differences in withdrawal time and lesion detection in 200 patients.  
Findings: Mean inspection time with Endocuff was 6.5 min vs 8.4 min for standard colonoscopy. Numbers of 
adenomas detected per colonoscopy, adenoma detection rate, number of sessile serrated polyps per 
colonoscopy, and sessile serrated polyp detection rate did not differ significantly with vs without Endocuff.  
Limitations: The study was performed by 2 examiners with extensive experience with Endocuff Vision. 
Implications for patient care: Inclusion of Endocuff in screening or surveillance colonoscopies decreases 
examination time without reducing lesion detection. 
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Introduction 
 Mucosal exposure devices that have shown promise for improving detection include 
Endocuff 1,2, Endocuff Vision 3, Endorings 4, and wide angle colonoscopy 5.  In a recent 
randomized trial, we showed that Endocuff on  a high definition colonoscope is a dominant 
strategy over Endorings and very wide angle colonoscopy, resulting in better detection, and 
faster insertion 2.  
 Another potential avenue of investigation for Endocuff, is whether these devices can 
speed withdrawal while maintaining stable or  improved levels of detection.  Video recording 
studies 6, demonstrate that high quality colonoscope withdrawal consists of careful inspection of 
the proximal sides of haustral folds, flexures, and colorectal valves, removal of retained pools of 
debris and fluid, and adequate colonic distention 6. Most of the work of withdrawal for high level 
detectors is the process of exposing the mucosa between haustral folds that could otherwise hide 
lesions during withdrawal.  Devices such as Endocuff can be used to hook and flatten haustral 
folds,  improving mucosal exposure.  However, an additional benefit of these devices is to make 
the process of examining between folds faster. 
 Studies of mucosal exposure devices have almost uniformly targeted polyp detection as 
their primary endpoint.  In  meta-analyses, Endocuff increased the adenoma detection rate 
(ADR) by an average of 7% 1.  However, some lines of uncontrolled evidence show that mucosal 
exposure devices are associated with both significantly better detection and shorter withdrawal 
time 7, or numerically better detection and significantly shorter withdrawal time 8.  To our 
knowledge, no previous randomized trial has specifically targeted withdrawal time as a primary 
endpoint.   
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The issue of how to handle withdrawal time and inspection time (the time spent actually 
examining the colon after subtraction of washing, suctioning, polypectomy, and biopsy) in 
controlled trials of colonoscopy is complex.  When the primary target of a randomized trial is 
detection, it may be best to force equal inspection times in the study arms.  Thus, in a 
randomized controlled trial comparing the Third Eye Retroscope to standard colonoscopy, 
withdrawal times were allowed to vary.  The results showed better detection with the Third Eye 
Retroscope, but withdrawal was also longer 9.  Since longer withdrawal times are associated with 
better detection and cancer prevention 10-12, allowing withdrawal time to vary cast uncertainty on 
the benefits of the Third Eye Retroscope for detection.  In some trials such as our recent 
comparison of Endocuff to Endorings to Full-Spectrum Endoscopy to standard colonoscopy, we 
forced equal inspection times in the four study arms 2, in order to avoid this confounding issue.   
 In the current trial, we specifically chose to study Endocuff Vision without forcing the 
inspection time to be equal to the control arm.  Instead the study colonoscopist tried to perform 
withdrawal as rapidly as they comfortably could expose hidden mucosa to their satisfaction.  The 
hypothesis was that withdrawal time could be shortened using Endocuff Vision, while 
simultaneously observing at least no reduction in detection employing Endocuff Vision.  
 
Methods 
 We performed a randomized controlled clinical trial comparing colonoscopy using 
Olympus high definition colonoscopes with or without Endocuff Vision (Arc Medical Design 
Ltd., Leeds, UK).  Endocuff Vision is marketed in the United States by Olympus (Olympus 
America Corp., Center Valley, PA).  Neither Arc Medical nor Olympus was involved in the 
study design or provided any devices or other support for the study, nor did they have access to 
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any study data at any time prior to publication of the study.  No funding source had any 
involvement in any aspect of the study.  The study was performed at academic outpatient units 
affiliated with Indiana University School of Medicine and NYU Langone Medical Center.  
Randomization was performed using a computer generated sequence.  The randomization was 
concealed in opaque numbered envelopes and opened after the informed consent was completed.  
Patients were enrolled and assigned to the study arms by research assistants at both sites.   
The primary endpoint was the inspection time.  Inspection time was measured during 
colonoscopy by a study assistant using a stopwatch.  Once the cecum had been intubated, 
retained material was washed and suctioned.  As soon as the cecum was prepared for evaluation, 
the stopwatch was started.  During withdrawal, the stopwatch was stopped anytime a polyp was 
detected, until its resection and retrieval had been completed and inspection started again.  The 
inspection time stopwatch was also stopped as often as necessary to clean out residual debris and 
pools of fluid until the colon was again ready for inspection. Assuming a mean inspection time in 
the control group without Endocuff Vision of approximately 9 minutes, we considered that a 
reduction in the mean time of 1 minute would be a valuable time savings over a large number of 
procedures.  For the study to have an 80% power to detect a 1 minute difference in inspection 
time between the groups, assuming the 2-sided, 2-sample t-test, a 5% significance level, and 
standard deviation of 2.5 minutes, a sample size of 200 total patients was needed.  The study was 
approved by the Institutional Review Board at Indiana University Health on November 30, 2017.  
The trial was listed at clinicaltrials.gov (NCT03361917). 
 The secondary endpoints were colonoscope insertion time and detection endpoints 
including adenoma detection rate, adenomas per colonoscopy, sessile serrated polyp detection 
rate, and sessile serrated polyps per colonoscopy.   
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Inclusion criteria included age ≥ 40 years, and indication for colonoscopy of screening or  
surveillance colonoscopy..  Patients were excluded if they had a polyposis syndrome, Lynch 
syndrome, inflammatory bowel disease, diagnostic indication, or a previous resection of the 
colon.  Patients were also excluded if they had known severe diverticular disease, were referred 
for a previous incomplete colonoscopy, or for a resection of a large colorectal polyp.   
 Statistical analyses were performed to determine if there were statistically significant 
differences between the devices using Generalized Estimating Equations (GEEs), which allow 
for the analysis of repeated measures on the visit level data through the use of the appropriate 
covariance structure, as well as accounting for site affect.  GEE models also allow for the 
modeling of both continuous and categorical outcomes, through the ability to specify the correct 
data distributions, which include standard ANCOVA methods, logistic regression models, and 
skewed continuous data.  Models were run both unadjusted and adjusted for age, gender, and 
race, which were included as covariates from both initial bivariate analyses and clinical 
relevance.  Data were also collapsed to patient level, allowing for analyses of summation and 
ever/never (i.e. any yes vs. all no) results, using the typical ANCOVA, logistic regression, and 
Chi-Square analyses.  All analytic assumptions were verified and all analyses were performed 
using SAS v9.4 (SAS Institute, Cary, NC). All authors had access to the study data and reviewed 
and approved the final manuscript.  
 
Results 
 There were 200 patients randomized, including 101 to Endocuff Vision and 99 to 
standard colonoscopy.  The mean patient age was 62.2 years, 50.5% were female, 89.5% white, 
70% (n=140) were randomized at Indiana University and 30% (n=60) at New York University.  
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Patients were recruited between 12/11/2017 and 04/18/2018.  The trial was stopped when 
planned enrollment was completed.  There was no interim analysis.   
Patients screened and excluded were tracked in Indianapolis only.  A total of 173 patients 
were screened there, of whom 27 were excluded including 2 for known severe diverticular 
disease.  The remaining patients were excluded for young age (n=9), referral for resection of a 
large polyp (n=8), prior colon resection (n=4), inflammatory bowel disease (n=2), Lynch 
Syndrome (n=1) and polyposis syndrome (n=1). Six screened patients refused participation.    A 
gastroenterology fellow assisted with the insertion of 32 (23%) cases at Indiana University, and 
no cases at New York University.  Table 1 compares the Endocuff Vision and standard 
colonoscopy groups by age, gender, race, site, indication, and whether a fellow assisted with 
insertion and bowel preparation quality.  The percentage of females in the standard group 
(57.6%) was higher than in the Endocuff Vision group (43.6%) p=0.048.  There were no other 
demographic differences between the study arms and none between study sites. 
 Table 2 shows the inspection and insertion times for the two study arms, after controlling 
for age, gender, and race.  The inspection time using Endocuff Vision was shorter at 6.5 min 
compared to 8.4 min with standard colonoscopy (p<0.001).  The absolute mean reduction in 
inspection time was 23% (mean 1.93 minutes).  Shorter inspection time also reached significance 
(p< 0.001) for each endoscopist independently (data not shown).   Overall withdrawal time 
(including polypectomy, washing and suctioning time) was more than twice as long when polyps 
were removed compared to no polyps removed (16.7 min vs 8.0 min; p < 0.001), indicating that 
polypectomy time was the largest contributor to overall withdrawal time.  The mean reduction in 
overall withdrawal time with Endocuff Vision compared to standard colonoscopy was 1 min but 
was not statistically significant (15.1 vs. 14.1 min; p=0.31).   In Indianapolis an adult 
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colonoscope was used in most cases.  In New York a pediatric colonoscope was used in all cases.  
The cecum was reached in all 200 patients.  Insertion time was numerically shorter using 
Endocuff Vision by 22 seconds, but this difference did not reach significance (p=0.143).   
 All detection endpoints numerically favored Endocuff though none of them reached 
statistical significance.  The number of adenomas per colonoscopy (1.43 versus 1.07; p=0.07), 
adenoma detection rate (61.4% versus 52%; p=0.206), sessile serrated polyps per colonoscopy 
(0.27 versus 0.21; p=0.120), sessile serrated polyp detection rate (19.8% versus 11.1%; 
p=0.090), were all numerically higher with Endocuff with similar results after controlling for 
age, gender, and race.  There were no significant differences between the study arms in 
prevalence of lesions ≥ 10 mm in size, or between the overall prevalence of any lesion type 
considered only in the proximal colon (proximal to the splenic flexure) or in the distal colon. 
 There were no complications in either arm. 
Discussion 
 In this study, we demonstrated that performance of colonoscopy with Endocuff Vision 
allowed shorter inspection times (23%), and by an average of almost 2 minutes, with no loss of 
detection.  Because withdrawal times are a continuous variable that are measured in every 
procedure performed in the study, it’s possible to demonstrate statistically significant differences 
in withdrawal time with considerably smaller sample sizes than are needed to demonstrate 
detection differences.  Despite that, the difference in adenomas per colonoscopy in the current 
study almost reached statistical significance in favor of Endocuff Vision, and all of the detection 
endpoints were numerically in favor of Endocuff Vision.  We 2 and others 1, have previously 
demonstrated in what are typically much larger studies, that when inspection times are forced to 
be equal, Endocuff results in statistically significant gains in detection 1,2.  Although the sample 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
size in the current study was not large enough, nor was the study designed to demonstrate both 
shorter inspection time and superior detection with Endocuff Vision, these data suggest that an 
appropriately powered study could demonstrate that Endocuff Vision can achieve both improved 
detection and shorter examination times. The absolute reduction in overall mean withdrawal time 
with Endocuff Vision, including polypectomy and all washing and suctioning was 1 minute, 
despite a one-third increase in the number of conventional adenomas and sessile serrated polyps 
removed in the Endocuff Vision arm. 
 In our study, more females were randomized to the standard colonoscopy arm than the 
Endocuff arm, and female gender is associated with a lower prevalence of polyps.  Despite that, 
the numerical trends toward higher detection for all detection endpoints persisted in 
multivariable analyses that controlled for age, gender, and race. 
We found that longer withdrawal times were associated with increasing age and male 
gender.  Since both of these factors are associated with increasing prevalence of adenomas, it’s 
possible that the longer times reflected bias on the part of the investigators, with additional time 
taken to avoid missing lesions.  Alternatively, anatomic factors involved in examining older 
colons in male patients may account for these differences. 
 The principle limitation of our study is that the investigators were not blinded to the 
device used.  However, this limitation is common to endoscopic studies, including essentially all 
studies centered on detection during colonoscopy.  Studies of this type depend on the 
investigators’ faithful attempt to minimize bias.  Our results have an obvious potential 
explanation from a mechanistic standpoint, and are consistent with previous uncontrolled studies 
of Endocuff 7 and Endorings 8.  Nevertheless, a full picture of the benefits of Endocuff Vision or 
any device cannot be ascertained without examining multiple studies, because the performance 
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of many aspects of colonoscopy, including the use of associated devices, is subject to operator 
dependence.  Because only two endoscopists performed the study, the generalizability of the 
results remains uncertain.  Therefore we encourage other investigators to undertake similar 
studies.  Further, both endoscopists were highly experienced with both Endocuff and Endocuff 
Vision, and the results may not apply to endoscopists with less experience with the devices. 
Finally, additional limitations were that we did not collect data on other potential confounders 
such smoking status and body mass index, and the study was not powered to detect differences in 
the prevalence of more clinically important lesions such as advanced adenomas or lesions ≥ 10 
mm in size. 
 Previous studies, including our own (2), showed that a small fraction of patients have 
sufficient sigmoid narrowing or angulation to require removal of Endocuff to achieve successful 
navigation of the sigmoid. In the current study no patient required removal of Endocuff Vision, 
though two patients at Indianapolis were excluded prior to recruitment for known severe sigmoid 
diverticular disease. Inclusion of patients 40-49 years old, who have a lower risk of severe 
diverticular disease compared to older persons, may have contributed to the finding. In general, 
clinicians should expect a small fraction of patients to require device removal for safe 
advancement through the sigmoid, and colonoscopy without the device should be considered in 
patients with known severe sigmoid diverticular disease. 
 Perspectives on whether the reduced inspection time observed in this trial with Endocuff 
Vision is clinically important, will depend on individual perspectives on efficiency in endoscopy.  
For extremely efficient endoscopists, one or two minutes time saving per procedure could be 
considered a significant gain when many procedures in a day or week are considered.  
Efficiency, which should never take place at the expense of quality, is often achieved through the 
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accumulation of numerous measures, each of which by itself may have a quantitatively small 
impact.  In any case, there are few situations described in which improvement in efficiency 
(reduction of inspection time) can be made without loss of detection.   
 In conclusion, we demonstrated in a randomized controlled trial that Endocuff Vision is 
associated with reductions in inspection time without loss of detection.  We recommend that 
other investigators examine the impact of Endocuff Vision on inspection and withdrawal times in 
addition to detection endpoints.  
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Table 1 Demographics, indications, and number of colonoscope insertions by fellows in the two 
study arms 
Demographic Endocuff 
Vision 
Standard 
colonoscopy 
p 
 n=101 n=99  
Screening/surveillance* 45/56 52/47 .322 
Age (years)** 62.7 (8.9) 61.7 (9.9) .446 
Female** 44 (43.6) 57 (57.6) .048 
White** 87 (86.1) 92 (92.9) .117 
Fellow assisting 
insertion** 
17 (16.8) 15 (15.2) .949 
*number of patients with screening/surveillance indication 
**Values are means (standard deviations) for continuous variables and frequencies (percentages) 
for categorical variables.   
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Table 2. Primary and secondary study results. 
 Endocuff Vision Standard p 
 n=101 n=99  
Inspection time 
(min) 
6.49 (0.10) 8.42 (0.12) <0.001 
Insertion time 
(min) 
4.05 (0.16) 4.42 (0.19) 0.143 
Boston Bowel 
Prep Score 
median (range) 
9 (3-9) 9 (3-9) 0.688 
Adenoma 
detection rate 
61.4% (51.6, 70.3) 52.5% (42.8, 62.1) 0.206 
Adenomas per 
colonoscopy 
1.43 (1.79) 1.07 (1.62) 0.077 
Sessile serrated 
polyp detection 
rate 
19.8% (13.2, 28.6) 11.1% (6.3, 18.8) 0.090 
Sessile serrated 
polyps per 
colonoscopy 
0.27 (0.63) 0.21 (0.70) 0.120 
Values are means (standard errors) for continuous variables, except where noted, and 
percentages (95% confidence intervals) for categorical variables.   
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Prospective Randomized controlled trial of High-Definition White-
light colonoscopy versus High-Definition White-light colonoscopy 
with Endocuff Vision for endpoints of procedural times 
 
 
Primary Investigator:   Dr. Douglas Rex, 
Indiana University Hospital 
Indianapolis, IN 46202 
 
 
Introduction: 
Endocuff Vision ( Olympus) is a disposable device that has 8 independently moving soft 
flexible arms arranged in a single row. The device comes in several sizes and can fit the tips of 
most commonly used colonoscopes. During intubation, the arms fall flat to the body of the 
scope as not to impede forward motion. Endocuff Vision is an FDA approved device that fits 
over the end of a colonoscope and has flexible soft fingers that project from the sides.  These 
fingers can be used to pull back the folds in the colon and expose mucosa on the proximal 
sides.  A number of studies indicate that Endocuff improves the adenoma detection rate 
(ADR) during colonoscopy.  In a non-randomized retrospective evaluation, Endocuff resulted 
in better detection, faster insertion, and faster inspection (1).  
 
Our aim in this study is to show in a prospective randomized trial Endocuff Vision could 
improve insertion because during loop withdrawal the cuff tends to stabilize the position of the 
tip, preventing its backward movement and speeding loop removal.  Similarly, during inspection, 
the main goal is to evaluate the proximal sides of folds and flexures.  The process is made easier 
and quicker by the device. Third, during polypectomy, Endocuff Vision helps to stabilize the 
position and the scope tip.   
 
Methods:  
This will be a prospective, randomized controlled study.  Subjects referred for screening or 
surveillance colonoscopy will be prospectively enrolled. They will be randomized to one of 
two arms, i.e High Definition colonoscopy or High Definition colonoscopy with Endocuff 
Vision. 
 
A member of the research team will approach a potential subject to discuss participation in the 
study, including background of the proposed study, inclusion and exclusion criteria, benefits 
and risks of the procedures and follow-up. If this is of interest to the subject, the informed 
consent form is discussed and presented. The subject must sign the consent form prior to 
enrollment. This form will have prior approval of the study site's Institutional Review Board 
(IRB). Failure to obtain informed consent renders the subject ineligible for the study 
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Objectives: 
Primary objectives of the study are: 
 To compare the insertion time, inspection time, the total time per polypectomy, and the 
total procedure time during High Definition colonoscopy with Endocuff Vision versus 
standard High Definition colonoscopy. 
 
Secondary objectives: 
 
 To compare the number of adenomas detected per subject with High 
Definition Endocuff Vision compared to Standard High Definition 
colonoscopy. 
 
 To compare the detection rates for polyp subtypes (including advanced   adenomas, 
serrated polyps, right sided adenomas, etc) for High Definition Endocuff Vision 
compared to Standard High Definition colonoscopy. 
 
Primary End-point:  
 
 The inspection  time will be shorter because the proximal sides of the folds are more 
quickly exposed with Endocuff Vision compared to standard colonoscope alone because 
of the ability of the Endocuff Vision to stabilize the position of the colonoscope tip 
during loop withdrawal, thus preventing its backward movement and speeding loop 
removal. 
 
 
Criteria: 
All colonoscopies in the study will be performed by a qualified professional. Patients will be 40 
and older and will be randomized to receive colonoscopy with or without the Endocuff.  Data 
collected will include the type of scope used (adult versus pediatric), age, gender, indication, 
history of prior abdominal surgery and type, identification of diverticulosis classified as mild 
moderate or severe, insertion time, total procedural time, total withdrawal time, inspection time 
(withdrawal time minus anytime suctioning, cleaning, and diagnostic biopsy or therapeutic 
procedure), and polypectomy time for each polyp removed. For each polyp, we will record the 
location, size, shape, and pathology.  
 
Inclusion criteria 
 
• Referral for screening or surveillance colonoscopy 
• Ability to provide informed consent 
• 40 years and older 
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Exclusion criteria 
 
• Prior history of colon cancer 
• History of inflammatory bowel disease 
• Prior surgical resection of any part of the colon 
• Use of anti-platelet agents or anticoagulants that precludes the removal of polyps 
during the procedure 
• History of polyposis syndrome or HNPCC 
• Inability to give informed consent 
• Family history of colon cancer in a first degree relative < 60 years or two first degree 
relatives with colorectal cancer 
 
 
 
Statistical Analysis and Sample Size: 
 
• Normally distributed continuous variables will be summarized using means and 
standard deviations while non-normally distributed continuous variables will be 
summarized using medians and ranges. 
 
• The primary endpoints for the study will be the inspection time and insertion time, , the 
total time per polypectomy, and the total procedure time. 
 
• The secondary endpoints will be total time per polypectomy, total procedure times, and adenomas 
detected. 
 
 
• All colonoscopies in the study will be performed by a qualified professional. Patients will 
be 40 and older and will be randomized to receive colonoscopy with or without the 
Endocuff.  Data collected will include the type of scope used (adult versus pediatric), age, 
gender, indication, history of prior abdominal surgery and type, identification of 
diverticulosis (classified as mild moderate or severe), insertion time, total procedural time, 
total withdrawal time, inspection time (withdrawal time minus anytime suctioning, 
cleaning, and diagnostic biopsy or therapeutic procedure), and polypectomy time for each 
polyp removed. For each polyp, we will record the location, size, shape, and pathology.  
 
There will be a sample size of 200 subjects enrolled in this study. 100 randomized into two 
groups. With the sample size of 100 per group, the study will have 80% power to detect a 1 
minute difference in the inspection time between the two groups. The inspection and insertion 
times will be compared using a two-sided two sample t-test, 5% significance level, and standard 
deviation of 2.5 minutes. 
The data will be analyzed and the statistics performed by persons in the biostatistics department.  
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Safety Risks to the patient and Data integrity: 
All paper charts pertaining to the patient will be kept under lock and key in coordinators office 
away from the endoscopy area. The data entry will be performed into an excel file which will 
be stored on an internal network drive with encryption and password security. Data 
management will include double data entry and regular back-up of the data. Only approved 
personnel by the IRB will have access to the file storage.  This file will also not have any 
identifiable information.  A study log with the identifiable information will be kept in a 
separate folder to enable the investigators to assist in any research audit. No procedural data 
except the date of examination will be entered into this log.  
 
Any subject who wishes to withdraw from this investigation on his/her own accord and for 
whatever reason is entitled to do so without obligation and prejudice to further treatment. In 
addition, the Investigator may decide for reasons of medical prudence, to withdraw a subject. In 
either event, the Investigator will clearly document the date and reason(s) for the subject’s 
withdrawal from this investigation in the CRF and should indicate whether or not he considers it 
was related to the study interventions. 
 
References: 
(1). ZP Tsiamoulos et al. Gastrointest Endosc. 2017 Apr 13. Impact of a New Distal Attachment 
on Colonoscopy Performance in an Academic Screening Center  
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Acronyms 
U.S.-United States 
vs-versus 
ADR-adenoma detection rate 
UK-United Kingdom 
PA-Pennsylvania 
NYU-New York University 
GEEs-Generalized Estimating Equations 
ANCOVA-analysis of covariance 
NC-North Carolina 
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In a randomized controlled trial targeted to inspection time during colonoscopy withdrawal, Endocuff 
Vision was associated with a 1.9 minute reduction in inspection time and numerical increases in all 
detection targets.   
